<DOC>
	<DOC>NCT03069404</DOC>
	<brief_summary>The investigation is a multi-year observational study following the completion of the open-label, single dose Phase I/II study involving transplantation of allogeneic HuCNS-SC cells into 12 subjects with thoracic spinal cord injury. Subjects will be monitored at routine intervals for safety and preliminary efficacy for 5 years post-transplantation of the Phase I/II investigation CL-N02-SC.</brief_summary>
	<brief_title>INSTrUCT-SCI: INdependent Observational STUdy of Cell Transplantation in SCI</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Must have undergone HuCNSSC transplantation as a subject in the Phase I/II trial Must be able to provide written informed consent prior to any study related procedures Must agree to comply in good faith with all conditions of the study and to attend all required study visits Female subjects who are pregnant remain eligible for enrollment, but the MRI examination will not be performed during the pregnancy. Female subjects of childbearing potential must have a negative urine pregnancy test prior to the MRI examination Subjects have received or are receiving offprotocol immunosuppressive medications Subjects who after completion of CLN02SC have entered, or are about to enter any other interventional study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>